2020
DOI: 10.1007/s10517-020-04821-w
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Genotoxicity of Perchlozone, Antituberculous Drug

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Later, in 2012, Perchlozone (Figure 1), another compound containing thiosemicarbazone scaffold, was approved in Russia for multi‐drug resistant TB treatment regimen [30] . In spite of the favorable toxicological properties of Perchlozone in preclinical and clinical studies, recent investigations in rats indicated genotoxic activity of the drug [31] . As may be seen, TSC is a promising antimycobacterial motif but there should be improvements in the therapeutic index of the drugs bearing it.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Later, in 2012, Perchlozone (Figure 1), another compound containing thiosemicarbazone scaffold, was approved in Russia for multi‐drug resistant TB treatment regimen [30] . In spite of the favorable toxicological properties of Perchlozone in preclinical and clinical studies, recent investigations in rats indicated genotoxic activity of the drug [31] . As may be seen, TSC is a promising antimycobacterial motif but there should be improvements in the therapeutic index of the drugs bearing it.…”
Section: Introductionmentioning
confidence: 99%
“…[30] In spite of the favorable toxicological properties of Perchlozone in preclinical and clinical studies, recent investigations in rats indicated genotoxic activity of the drug. [31] As may be seen, TSC is a promising antimycobacterial motif but there should be improvements in the therapeutic index of the drugs bearing it. On the basis of the aforementioned findings, the aim of this work is to further explore the synthetic utility of levoglucosenone, focusing on the development of novel antituberculosis agents derived from this chiral synthon that contains a thiosemicarbazone pharmacophore.…”
Section: Introductionmentioning
confidence: 99%